Australia
The Australian biotech market, which was valued at nearly $23 billion last year, is expected to see some positive growth to $25.2 billion by 2025, according to a GlobalData analysis.
Mr Buccilli commenced with the Company in June 2014 as CFO and was appointed CEO in February 2015.
The group has bought 11 businesses in the past seven years.
The Annual Report is available on the Company’s website at www.gtglabs.com
Osprey Medical today released its Appendix 4C – Quarterly Cashflow Report for the period ending 30 September 2017.
Biotech has been on fire this year, with the iShare Nasdaq Biotechnology index more than doubling the gains of the S&P 500 year-to-date.
PRESS RELEASES